Access to basic healthcare across many rural communities in Ghana remains a daily struggle, and for two young medical doctors, the urge to bridge the gap became a shared responsibility.

The challenges were not mere statistics but lived realities that inspired the groundbreaking medicinal innovation that is now gaining nationwide attention. Bora marks a defining moment in time where traditional medicine is backed by scientific evidence.

The journey began not in laboratories, but in underserved communities of rural Ghana where trust for orthodox medicine was shaken by insurmountable traditional beliefs and financial constraints. Working through Community-based Health Planning Service (CHPS) compounds and outreach programs, the doctors encountered patients who, despite receiving prescriptions often left the prescriptions unused—tucked under pillows due to skepticism, misinformation and to a large extent lack of affordability.

Facing this stark reality, these doctors adopted an ethnographic approach, immersing themselves in the life and beliefs of the people they served, and what they discovered was a deep-rooted reliance on traditional remedies as well as a growing need for healthcare solutions that were both economically feasible and culturally acceptable. An experience that marked the foundation of a new path—one that would merge scientific rigor with traditional confidence.

Match Made by The gods

The talented young doctors are the founders of the African Rural Doctors Association, an initiative that gives back to underserved communities with focus on maternal and child health. A rigorous journey focused on understanding the minds and medicinal challenges of the rural communities they served. After numerous consultations and discussions, they joined forces with another group of talented young men emerging on Ghana’s herbal pharmaceutical scene (UHARA Pharmaceutical Company Ltd), and with a great team spirit, they put together a conglomerate of ideas that set forth research into an age-old tested Ghanaian traditional formulation passed down generations by ancestral folklore apprenticeship in plant-based medicine. 

The aim was to understand the exact constituents and active ingredients of the formulation in order to develop measurable, reproducible as well as appropriate proportions of each active ingredient to yield dose calculation towards a desired therapeutic effect. Further studies were to be considered for drug safety via metabolism, pharmacokinetics as well as pharmacodynamics with target organs for excretion, paying attention to drug toxicity, cytochrome enzyme interactions in relation to other chemical compounds, adverse drug reactions and side effects. 

From Tradition to Laboratory

A team of six young and intelligent comrades embarked on a mission to scientifically validate a Ghanaian heritage of herbal medicine that had been used informally for decades. Their goal was not to replace orthodox medicine, but to make a formal statement that compliments it as an alternative —especially in areas it struggled to reach.

Samples of their formulation were submitted to The Centre for Plant Medicine Research in Mampong Ekuapem, where laboratory analysis confirmed the presence of beneficial phytochemicals such as saponins, triterpenes, flavonoids, and phytosterols. Further testing declared the formulation safe, non-toxic, and free from significant microbial contamination.

A Synergy of Three Powerful Plant-based Molecules

At the heart of Bora Herbal Capsules is a carefully balanced blend of three medicinal plant-based molecules long used in African folklore medicine:

• Alstonia Boonei: Known for its anti-inflammatory, pain-relieving, and antimalarial properties.

• Rauwolfia Vomitoria: Recognized for its blood pressure-lowering and calming effects.

• Paullinia Pinnata: Valued for its antimicrobial, antioxidant, and tissue-healing effects.

Together, these botanicals form a synergy that targets inflammation, improvement of circulation, and support of the body’s natural healing processes.

Target of Commonly Neglected Conditions

Bora Herbal Capsules have been developed specifically for conditions that significantly impact quality of life yet under-treated in rural settings. For women suffering from dysmenorrhea (menstrual pain), the capsules help reduce uterine cramps, pelvic inflammation, and overall discomfort. For individuals dealing with hemorrhoids, the formulation addresses pain, swelling, itching and bleeding, whilst promoting tissue healing.

Clinical guidance recommends a dosage of 1000mg orally twice daily, with specific timing depending on the condition being treated.

Safety and Responsible Use

On October 31, 2025, Ghana’s Food and Drugs Authority officially certified the product—Bora Herbal Capsules—as safe and effective for the treatment of hemorrhoids and dysmenorrhea (menstrual pain).

Whilst the product has been approved as safe, medical experts emphasize the importance of proper usage. Considering side effects such as dizziness, stomach discomfort, and drowsiness  occurring due to certain potent plant compounds—particularly those in Rauwolfia Vomitoria. Patients are advised to use the medication under professional guidance especially in patients taking antihypertensives and antidepressants.

The capsules are not recommended for pregnant or breastfeeding women, individuals with severe low blood pressure, or those with a history of depression and Parkinson’s disease. Avoid use with chemotherapeutic agents and blood thinners.

A New Chapter in African Medicine

Bora Herbal Capsules represent more than just a pharmaceutical product—it symbolizes a shift in how healthcare can be delivered in Africa. By blending traditional evidence with modern scientific validation, the initiative offers a model for developing culturally acceptable, affordable and accessible treatments.

For the six talents behind this innovation, rural medicine continues to evolve, and Bora stands as a testament to what is possible when scientific research backs tradition on a mission that remains clear, that when a herbal product is to be considered, it must go through necessary channels to ensure safety as well as its therapeutic effects and mostly cost effective for the target population.

Author: Dr. Mark Adjetey Abban MD, MBChB.

Accolades:

• Founding members of UHARA Pharmaceutical Company Ltd. Dr Derrick Kofi Denteh, Mr

Desmond Denteh, Mr Daniel Blessing Soglo, Mr Prosper Boadu, Dr Seth Effah Agyei

• Founders of the African Rural Doctors Association; Dr Mark Adjetey Abban MD, MBChB, Dr Seth Effah Agyei MD, MBChB.